Is Eli Lilly an Undervalued Growth Stock to Buy Now? | Lilly Stock Analysis | Eli Lilly Stock DCF

Eli Lilly is generating billions in cash flow growth due to product innovation.

Unlock the power of intelligent investing with my six-step investing framework—a proven system designed by a university professor and Chartered Financial Analyst (CFA). Frustrated by the lack of frameworks that met my needs and high standards, I developed this comprehensive guide to help investors at all levels make confident, informed decisions. In this book, you'll learn how to assess opportunities, manage risk, and build a portfolio that works for you. No investor should dive into the market without a solid strategy, and this step-by-step framework provides the roadmap you need. Whether you're just starting or looking to refine your approach, this guide will empower you to take control of your financial future.

The Motley Fool Stock Advisor returns are 780% as of 9/26/2024 and measured against the S&P 500 returns of 168% as of 9/26/2024. Past performance is not an indicator of future results. All investing involves a risk of loss. Individual investment results may vary, not all Motley Fool Stock Advisor picks have performed as well.

Moomoo Investing App: Discover a powerful investment app that lets you easily buy and sell stocks, ETFs, and more, all in one user-friendly platform. Whether you’re new to investing or an experienced trader, this app makes managing your investments simple, secure, and accessible.
Plus, for a limited time, when you sign up using the exclusive link, you can receive up to 15 free stocks—a perfect boost to kickstart your portfolio. Don’t miss out on this limited offer; take charge of your financial future today!

About Me: I am a university professor specializing in business, finance, economics, and accounting, with extensive experience as a Chartered Financial Analyst (CFA). In addition to teaching, I am the author of Make Money Buying and Selling Stocks: A 6-Step Framework for Evaluating Publicly Traded Companies. Over the years, I have published thousands of videos and written over 2,000 articles for The Motley Fool, sharing insights on investing and personal finance. My passion lies in empowering others to make informed financial decisions through education and practical, proven frameworks.


Disclaimer: The content on this channel is for entertainment purposes only and should not be considered financial, legal, or investment advice. While I share my opinions and insights, I am not a licensed financial advisor. Always do your own research and consult with a professional before making any financial decisions. The creator is not responsible for any actions taken based on the information provided in the videos.

Parkev Tatevosian will earn a commission or referral bonus for sending traffic to partner sites.

[vaclavbechynak]

Thanks Parkev, and I wish you Merry Christmas and good health!

[roxiebeagle]

With Novo Nordisk falling so much in the last week- this might be a perfect time for you to do an analysis on NVO!

[James-jdiw]

Can you compare Novo and Lily? This would be a fantastic video!
Thanks professor, I love your videos

[有福-gz]

Thanks for the analysis. I think the long-term growth rate is too optimistic. Once patent is up, profit can drop dramatically. Also, competitors can come up with better alternative.

Lly is a drug to have in the portfolio. But to say that its current intrinsic values is worth over $2000... no way... if you pay $2000 for this stock in 2025, expect to suffer a crash at some point.

[higorcarvalho]

Thank you for the video! Always useful information!

[pruthvibhupathirajuvenkata]

Hi Parkev. I am member of your youtube channel. Could you please do a video on Grab

[bobsonvb]

Thanks for the video! Where can I find this calculator?

[thethrill]

Is there a chance you can do United Healthcare VS Elevance . Thanks

[avirao]

Happy holidays Parkev. Any luck on revisiting confluent?

[davidvillanueva]

Thanks for the video 😊
Any advice on bitfarms stock?

[AkshaySarraf]

From where do you get the free cash flow numbers from 2024 to 2028? Can you share the source?

[muratcaglaroz]

Would you please use 2 different valuation methods. Is DCF good method?

[latrellmccrory]

can you do an analysis on Texas Instruments

[globalcapitalmarketsllc]

I hope you guys are aware of the background: Lilly vs.Twitter X